|
Description:
|
|
Featuring articles on azithromycin for seasonal malaria chemoprevention, azithromycin to prevent childhood mortality in Niger, a follow-up of intensive glucose control in type 2 diabetes, and on venetoclax and obinutuzumab in CLL; review articles on cancer stem cells and on the prevention of opioid overdose; a Clinical Problem-Solving describing a disturbing decline; and Perspective articles on measles in 2019, on whether CBO forecasting is good enough for government work, on getting more savings from ACOs, and on innovation in genomic data sharing at the NIH. |